Jin-long Chen, Chief Scientific Officer at NGM BIOPHARMACEUTICALS INC (NGM), sold 50,000 shares at $27.59 ($1.4M) on 2020-12-14, disclosed to the SEC on 2020-12-16.
Open-market sale of $1.4M NGM by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.59 | 11,126 | $307K | 21.9% |
| 2 | $27.59 | 11,126 | $307K | 21.9% |
| 3 | $28.19 | 10,729 | $302K | 21.6% |
| 4 | $28.19 | 10,729 | $302K | 21.6% |
| 5 | $28.89 | 3,145 | $91K | 6.5% |
| 6 | $28.89 | 3,145 |
| $91K |
| 6.5% |
| Total | $28.01 avg | 50,000 | $1.4M | 100% |
| Filing → |
| NGM | SELL | 2021-11-16 | $592K | — | Filing → |
| NGM | SELL | 2021-10-13 | $608K | — | Filing → |
| NGM | SELL | 2021-09-14 | $1.5M | — | Filing → |